These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33506478)

  • 21. OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review.
    Ahmadi N; Peng Y; Wolfien M; Zoch M; Sedlmayr M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Data harmonization and federated learning for multi-cohort dementia research using the OMOP common data model: A Netherlands consortium of dementia cohorts case study.
    Mateus P; Moonen J; Beran M; Jaarsma E; van der Landen SM; Heuvelink J; Birhanu M; Harms AGJ; Bron E; Wolters FJ; Cats D; Mei H; Oomens J; Jansen W; Schram MT; Dekker A; Bermejo I
    J Biomed Inform; 2024 Jul; 155():104661. PubMed ID: 38806105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of CPRD AURUM Data into the OMOP Common Data Model.
    Mayer CS
    Inform Med Unlocked; 2023; 43():. PubMed ID: 38046363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership.
    FitzHenry F; Resnic FS; Robbins SL; Denton J; Nookala L; Meeker D; Ohno-Machado L; Matheny ME
    Appl Clin Inform; 2015; 6(3):536-47. PubMed ID: 26448797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
    Shin SJ; You SC; Park YR; Roh J; Kim JH; Haam S; Reich CG; Blacketer C; Son DS; Oh S; Park RW
    J Med Internet Res; 2019 Mar; 21(3):e13249. PubMed ID: 30912749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM).
    You SC; Lee S; Cho SY; Park H; Jung S; Cho J; Yoon D; Park RW
    Stud Health Technol Inform; 2017; 245():467-470. PubMed ID: 29295138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming Estonian health data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model: lessons learned.
    Oja M; Tamm S; Mooses K; Pajusalu M; Talvik HA; Ott A; Laht M; Malk M; Lõo M; Holm J; Haug M; Šuvalov H; Särg D; Vilo J; Laur S; Kolde R; Reisberg S
    JAMIA Open; 2023 Dec; 6(4):ooad100. PubMed ID: 38058679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
    Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
    Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming Two Decades of ePR Data to OMOP CDM for Clinical Research.
    Lima DM; Rodrigues-Jr JF; Traina AJM; Pires FA; Gutierrez MA
    Stud Health Technol Inform; 2019 Aug; 264():233-237. PubMed ID: 31437920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards ETL Processes to OMOP CDM Using Metadata and Modularization.
    Peng Y; Henke E; Sedlmayr M; Bathelt F
    Stud Health Technol Inform; 2023 May; 302():751-752. PubMed ID: 37203486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards the Representation of Genomic Data in HL7 FHIR and OMOP CDM.
    Peng Y; Nassirian A; Ahmadi N; Sedlmayr M; Bathelt F
    Stud Health Technol Inform; 2021 Sep; 283():86-94. PubMed ID: 34545823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model.
    Bompelli A; Li J; Xu Y; Wang N; Wang Y; Adam T; He Z; Zhang R
    AMIA Annu Symp Proc; 2020; 2020():243-252. PubMed ID: 33936396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative patient-level prediction study in OMOP CDM: applicative potential and insights from synthetic data.
    Ahmadi N; Nguyen QV; Sedlmayr M; Wolfien M
    Sci Rep; 2024 Jan; 14(1):2287. PubMed ID: 38280887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility Study of Federated Learning on the Distributed Research Network of OMOP Common Data Model.
    Lee GH; Park J; Kim J; Kim Y; Choi B; Park RW; Rhee SY; Shin SY
    Healthc Inform Res; 2023 Apr; 29(2):168-173. PubMed ID: 37190741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usability of OMOP Common Data Model for Detailed Lab Microbiology Results.
    Theron E; Gorse JF; Gansel X
    Stud Health Technol Inform; 2022 May; 294():292-296. PubMed ID: 35612079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming Thyroid Cancer Diagnosis and Staging Information from Unstructured Reports to the Observational Medical Outcome Partnership Common Data Model.
    Yoo S; Yoon E; Boo D; Kim B; Kim S; Paeng JC; Yoo IR; Choi IY; Kim K; Ryoo HG; Lee SJ; Song E; Joo YH; Kim J; Lee HY
    Appl Clin Inform; 2022 May; 13(3):521-531. PubMed ID: 35705182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaption of the OMOP CDM for Rare Diseases.
    Zoch M; Gierschner C; Peng Y; Gruhl M; Leutner LA; Sedlmayr M; Bathelt F
    Stud Health Technol Inform; 2021 May; 281():138-142. PubMed ID: 34042721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Illustration of Continuous Enrollment and Beneficiary Categorization in DoD and VA Infrastructure for Clinical Intelligence.
    Pav V; Burns A; Colahan C; Robison B; Kean J; DuVall S
    Mil Med; 2024 Feb; 189(3-4):466-474. PubMed ID: 36461620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardizing Austrians Claims Data Using the OMOP Common Data Model: A Feasibility Study.
    Haberson A; Rinner C; Gall W
    Stud Health Technol Inform; 2019; 258():151-152. PubMed ID: 30942734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
    Hauben M; Aronson JK; Ferner RE
    Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.